Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery

<div>Percentage cell viability after being treated with <i>α</i>-mangostin either entrapped in Tf-LPHN (orange), Ctrl-LPHN (green), or as a drug solution (purple) on MCF-7 (a), A549 (b), and B16–F10 (c) cell lines, for 48 h (<i>n</i> = 4).</div>

The Scientific World Journal

fig5

Figure 5

Figure 5: Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery 

Figure 5 | Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery 